CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing advanced nano-carriers for cancer vaccines using block copolymer vesicles. These carriers aim to improve the delivery of antigens and adjuvants to immune cells, enhancing the effectiveness of cancer therapies while minimizing side effects.
Advanced designed vaccines have to combine proper antigen with the effective immune-stimulating agents (adjuvants) and delivery strategies in order to attain successful treatment.
Presently, most vaccines are given as liquid formulations by intramuscular administration.
However, nano-sized carriers of antigens hold great promise to be more effective delivery systems.
To achieve the desired anti-cancer therapy; the ideal antigen nano-carrier has to fulfil a number of requirements.
First of all ca…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
